Timothy Block, President and Co-founder of the biotech center and president of the Hepatitis B Foundation and the Baruch S. Blumberg
Today, Sofia serves on the faculty of the Baruch S. Blumberg
Institute, the research institute of the Hepatitis B Foundation, and is Chief Scientific Officer of Arbutus Biopharma.
Block, president of the Baruch S. Blumberg
Institute and the Pennsylvania Biotechnology Center.
Baruch S. Blumberg
, who received the Nobel Prize in Medicine in 1976 for his discovery of the hepatitis B virus.
The Baruch S. Blumberg
Institute and The Commonwealth Medical College (TCMC) will hold an open house for participants to learn about a new Master of Biomedical Science (MBS) program and meet with faculty, admissions counselors and financial aid representatives.
Timothy Block, president and co-founder of the Hepatitis B Foundation and its research arm, the Baruch S. Blumberg
The Baruch S. Blumberg
Institute, the research arm of the Hepatitis B Foundation, will host the 15th Annual Regional Biotech Conference, themed "Decreasing the Cost of Drug Development," at its headquarters at the Pennsylvania Biotechnology Center in Doylestown, Pennsylvania.
Doylestown, PA, July 25, 2015 --(PR.com)-- The Baruch S. Blumberg
Institute on July 16 hosted the inaugural "Entrepreneur Spotlight" at the Pennsylvania Biotechnology Center of Bucks County, attracting biotech executives and business leaders from across the region to the Shark Tank-style program and awards ceremony.
Eugene Schiff, Director of the Schiff Center for Liver Diseases at the University of Miami Miller School of Medicine, was awarded the 2015 Baruch S. Blumberg
Prize, the highest scientific honor that the foundation confers, for his pioneering work in hepatitis B and its medical management.
Doylestown, PA, May 03, 2015 --(PR.com)-- The Baruch S. Blumberg
Institute (www.blumberginstitute.org) and the University of Pennsylvania have formed a partnership that will offer graduate students valuable laboratory experience while bringing additional research support to the Institute's research programs.
Doylestown, PA, March 28, 2015 --(PR.com)-- The Baruch S. Blumberg
Institute (www.blumberginstitute.org) has recruited a new team of nationally renowned scientists to focus exclusively on research to develop a cure for hepatitis B, a move that nearly triples its research capacity and has created the largest concentration of nonprofit scientists focusing solely on hepatitis B and liver cancer in the United States.
Formerly the chief operating officer of a national behavioral health organization, Kassa will oversee daily operations at the Pennsylvania Biotech Center, which is home to the Hepatitis B Foundation and its research entity, the Baruch S. Blumberg